Pricing Log in Create free account

Edesa Biotech, Inc. (EDSA) vs Metagenomi Therapeutics, Inc. (MGX)

Edesa Biotech, Inc. and Metagenomi Therapeutics, Inc. are both Biotechnology companies. Edesa Biotech, Inc. and Metagenomi Therapeutics, Inc. are of similar size ($28.8M and $27.6M). Edesa Biotech, Inc. grew revenue faster over the last twelve months: −43.5% against −59.8%. Edesa Biotech, Inc. has the higher net margin (0.00% vs −689.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Edesa Biotech, Inc. leads on 8 and Metagenomi Therapeutics, Inc. on 7.

Valuation

Metric EDSA MGX Biotechnology median
P/E n/m n/m 10.60
P/S 59.44 1.94 9.40
P/B 48.99 0.23 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.66 0.66
EV/Sales 28.02 (4.72) 9.02
Earnings yield (77.88%) (355.71%) (32.88%)
Free cash flow yield (45.60%) (325.47%) (23.13%)

Profitability

Metric EDSA MGX Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% (741.58%) 0.00%
Net margin 0.00% (689.20%) 0.00%
Free cash flow margin 0.00% (632.67%) 0.00%
Return on equity (531.32%) (60.61%) (51.96%)
Return on assets (102.46%) (41.91%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric EDSA MGX Biotechnology median
Revenue growth (TTM) (43.48%) (59.84%) 6.76%
EPS growth (last fiscal year) 34.20% 0.00% 29.88%
Revenue growth, 5-year CAGR (15.40%) — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric EDSA MGX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.76 4.50 4.97
Net debt to EBITDA 1.39 1.71 1.01

Dividend

Metric EDSA MGX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric EDSA MGX Biotechnology median
Market cap 28.78m 27.60m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack